Chronic gastrointestinal symptoms in Korean population

December 29, 2008

Chronic gastrointestinal symptoms are highly prevalent in different geographic populations and cause various gastrointestinal symptoms that greatly inconvenience the lives of those affected. Examples include GERD, uninvestigated dyspepsia, irritable bowel syndrome, and chronic constipation. These problems have an impact on the individual's quality of life. There is a lack of community-based research evaluating the impact of chronic gastrointestinal symptoms on the quality of life.

A research article to be published on November7, 2008 in the World Journal of Gastroenterology addresses this issue. A research team led by Professor Choi and Jeong from The Catholic University of Korea performed a cross-sectional survey on randomly selected residents in Asan-Si, Korea. The authors assessed chronic gastrointestinal symptoms, using a Rome II based questionnaire. HRQOL was assessed using the Korean version of the SF-36. Of the 1807 eligible subjects, 1417 (78.4%: male 762; female 655) were surveyed, with a face-to-face interview.

The prevalence of gastroesophageal reflux disease (GERD), defined as heartburn and/or acid regurgitation experienced at least weekly, was 3.5. The prevalence of uninvestigated dyspepsia, irritable bowel syndrome (IBS) and chronic constipation, defined by Rome II criteria was 11.7%, 2.2%, and 2.6%, respectively. Compared with those not having chronic gastrointestinal symptoms (n = 1153), subjects with GERD (n = 50), uninvestigated dyspepsia (n = 166) and IBS (n = 31) had significantly worse scores on most domains of the SF-36 scales. The negative impact was greater in females, the elderly, subjects with a low economic class, and those with higher physician visits, and overlapping symptoms.

Based upon this research, it can be concluded that the quality of life was significantly impaired in subjects with GERD, uninvestigated dyspepsia and IBS. It can be reasoned that a better understanding of the impact of these disorders on all aspects of health, both mental and physical, may help in planning appropriate treatment interventions in these conditions.
-end-
Reference: Jeong JJ, Choi MG, Cho YS, Lee SG, Oh JH, Park JM, Cho YK, Lee IS, Kim SW, Han SW, Choi KY, Chung IS. Chronic gastrointestinal symptoms and quality of life in the Korean population. World J Gastroenterol 2008; 14(41):6388-6394 http://www.wjgnet.com/1007-9327/14/6388.asp

Correspondence to: Myung-Gyu Choi, MD, Professor of Medicine, Division of Gastroenterology, Department of Internal Medicine, Kangnam St. Mary's Hospital, The Catholic University of Korea, #137-040, 505, Banpo-Dong, Seocho-Gu, Seoul, South Korea. choim@catholic.ac.kr Telephone: +82-2-5902471 Fax: +82-2-5902387

About World Journal of Gastroenterology

World Journal of Gastroenterology (WJG), a leading international journal in gastroenterology and hepatology, has established a reputation for publishing first class research on esophageal cancer, gastric cancer, liver cancer, viral hepatitis, colorectal cancer, and H pylori infection and provides a forum for both clinicians and scientists. WJG has been indexed and abstracted in Current Contents/Clinical Medicine, Science Citation Index Expanded (also known as SciSearch) and Journal Citation Reports/Science Edition, Index Medicus, MEDLINE and PubMed, Chemical Abstracts, EMBASE/Excerpta Medica, Abstracts Journals, Nature Clinical Practice Gastroenterology and Hepatology, CAB Abstracts and Global Health. ISI JCR 2003-2000 IF: 3.318, 2.532, 1.445 and 0.993. WJG is a weekly journal published by WJG Press. The publication dates are the 7th, 14th, 21st, and 28th day of every month. WJG is supported by The National Natural Science Foundation of China, No. 30224801 and No. 30424812, and was founded with the name of China National Journal of New Gastroenterology on October 1, 1995, and renamed WJG on January 25, 1998.

World Journal of Gastroenterology

Related Irritable Bowel Syndrome Articles from Brightsurf:

Giant spider provides promise of pain relief for irritable bowel syndrome
Molecules from the venom of one of the world's largest spiders could help University of Queensland-led researchers tailor pain blockers for people with irritable bowel syndrome (IBS).

An aspirin a day keeps the bowel doctor away
A regular dose of aspirin to reduce the risk of inherited bowel cancer lasts at least 10 years after stopping treatment, research has revealed.

Mindfulness program may benefit patients with irritable bowel syndrome
Adults with irritable bowel syndrome experienced fewer gastrointestinal symptoms after they participated in a mindfulness program meant to reduce stress.

The Lancet Gasteroenterology & Hepatology: First clinical trial finds probiotic treatment with dead bacteria is better than placebo at alleviating symptoms of irritable bowel syndrome
Probiotic bacteria that have been killed by heat can significantly improve symptoms of irritable bowel syndrome (IBS) compared to placebo, and are not associated with any safety risk, according to a new 12-week, randomized, double-blind, placebo-controlled clinical trial with 443 patients published in The Lancet Gastroenterology & Hepatology journal.

Are steroids used too much for patients with inflammatory bowel disease?
Steroid therapy is commonly used to treat acute attacks of the inflammatory bowel diseases ulcerative colitis and Crohn's disease; however, because it does not provide long-term benefits and it carries a risk of serious side effects, it should not be used to treat inflammatory bowel disease for more than three months.

New, noninvasive test for bowel diseases
Gut diseases such as inflammatory bowel disease (IBD) are increasingly prevalent worldwide, especially in industrialized countries.

HKBU discovers mechanisms underlying early life stress and irritable bowel syndrome
Researchers from Hong Kong Baptist University have found that the abnormal rise of a soluble protein called Nerve Growth Factor is a key factor linking early life stress to the development of irritable bowel syndrome.

Microbiome science may help doctors deliver more effective, personalized treatment to children with irritable bowel syndrome
To improve the treatment of children with irritable bowel syndrome (IBS), investigators have developed a sophisticated way to analyze the microbial and metabolic contents of the gut.

The Lancet Gastroenterology & Hepatology: Hypnotherapy could help relieve irritable bowel syndrome symptoms
Peer-reviewed / Randomised Controlled Trial / People Gut-directed hypnotherapy delivered by psychologists appears as effective in group or individual sessions, potentially offering a new treatment option for irritable bowel syndrome in primary and secondary care

Early source of irritable bowel syndrome discovered
Michigan State University scientists have identified an early cause of intestinal inflammation, one of the first stages of inflammatory bowel disease and irritable bowel syndrome, which afflict around 11 percent of the world's population.

Read More: Irritable Bowel Syndrome News and Irritable Bowel Syndrome Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.